Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations
F1000Research · 2024
DOI: 10.12688/f1000research.143633.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2024. Verfasst von Haruna Luz Barazorda-Ccahuana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Catolica de Santa Maria de Arequipa, Pedro Vilcapaza…. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Mutation, Molecular Dynamics Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Catolica de Santa Maria de Arequipa.
Abstract (Originalsprache)
Background
Although the COVID-19 pandemic has diminished in intensity, the virus continues to circulate globally. The SARS-CoV-2 main protease (Mpro) is a key enzyme in the life cycle of the virus, making it important for the development of treatments against future variants of the virus. In this work, Peruvian natural compounds were evaluated against different mutations of the SARS-CoV-2 Mpro.
Methods
In silico techniques such as virtual screening, all-atom molecular dynamics simulations, and energy estimation analysis were applied.
Results
Of the tested compounds by virtual screening, rutin was identified as the best binding agent against the different proposed Mpro mutations. In addition, computational simulations and energy estimation analysis demonstrated the high structural and energetic stability between the Mpro-rutin systems.
Conclusions
Overall, our study identified rutin as the most promising compound with a strong affinity for various Mpro mutations, potentially playing a key role in the development of new treatments for emerging viral variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Catolica de Santa Maria de Arequipa, Pedro Vilcapaza, Arequipa, 04000, Peru.
- Facultad de Ciencias Farmaceuticas, Bioquímicas y Biotecnológicas, Universidad Catolica de Santa Maria de Arequipa, Pedro Vilcapaza, Arequipa, 04000, Peru.
- Sustainable Innovative Biomaterials, Le Qara Research Center, Arequipa, Peru.
ORCID-Profile: Haruna Luz Barazorda-Ccahuana, Angela Emperatriz Centeno-Lopez, Margot Paco-Chipana, Luis Daniel Goyzueta-Mamani, Miguel Angel Chavez-Fumagalli
Förderung
- Universidad Catolica de Santa Maria de Arequipa
Zitieren
APA
Barazorda-Ccahuana, H. L., Cárcamo Rodriguez, E. G., Centeno-Lopez, A. E., Paco-Chipana, M., Goyzueta-Mamani, L. D., & Chavez-Fumagalli, M. A. (2024). Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations. F1000Research. https://doi.org/10.12688/f1000research.143633.3
Vancouver
Barazorda-Ccahuana HL, Cárcamo Rodriguez EG, Centeno-Lopez AE, Paco-Chipana M, Goyzueta-Mamani LD, Chavez-Fumagalli MA. Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations. F1000Research. 2024. doi:10.12688/f1000research.143633.3
BibTeX
@article{BarazordaCcahuana2024,
author = {Barazorda-Ccahuana, Haruna Luz and Cárcamo Rodriguez, Eymi Gladys and Centeno-Lopez, Angela Emperatriz and Paco-Chipana, Margot and Goyzueta-Mamani, Luis Daniel and Chavez-Fumagalli, Miguel Angel},
title = {Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.143633.3}
}
EUVIMED